GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Kestra Medical Technologies
Kestra, a privately held medical technology company, is valued by the success of its wearable defibrillator. The potential share price will depend on sales volume, insurance approval, and competition from other devices for preventing sudden cardiac arrest.
Share prices of companies in the market segment - Heart
Kestra Medical, a privately held company that produces wearable defibrillators, is valued at the adoption of its technology in medical practice. We classify it in the Heart sector, and the chart below reflects the dynamics of the entire cardiac medical device industry.
Broad Market Index - GURU.Markets
Kestra Medical develops and manufactures wearable defibrillators for patients at risk of sudden cardiac arrest. As an innovator in cardiology, it is included in the GURU.Markets index. The chart below represents the market. See how Kestra shares compare to the medical equipment sector.
Change in the price of a company, segment, and market as a whole per day
KMTS - Daily change in the company's share price Kestra Medical Technologies
The daily price change of Kestra Medical, a developer of wearable defibrillators, reflects innovations in cardiology. Change_co shows sensitivity to regulatory approvals and market acceptance of the technology. This metric is important for analyzing the medical technology sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Heart
The medical technology sector in which Kestra Medical Technologies operates is highly dynamic. This chart reflects the industry's average volatility. It serves as a benchmark for assessing how sensitive Kestra's cardiac device development business is to overall trends and competition.
Daily change in the price of a broad market stock, index - GURU.Markets
Kestra Medical is a private company that has developed a wearable defibrillator. Its potential IPO will depend heavily on the market's appetite for medical technology innovation. The chart below shows the general volatility that affects the fate of such "unicorns."
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Kestra Medical Technologies
Kestra Medical is a medical technology company. Its success depends on its ability to commercialize its unique developments. Shares of such small, innovative companies often exhibit high volatility, contributing to overall market "noise."
Annual dynamics of market capitalization of the market segment - Heart
Kestra, a privately held company, develops wearable defibrillators. Its growth is driven by the rapid adoption of its technology in hospitals and among patients. Its valuation is likely outpacing the medical device sector, reflecting the high potential of its innovative product to save lives.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Kestra Medical Technologies is privately held and not publicly traded. Its market performance cannot be analyzed. As a developer of wearable defibrillators, its business operates at the intersection of medicine and technology, and its success is determined by clinical data and the ability to bring a product to market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Kestra Medical Technologies
Kestra's performance as a medical technology company will depend on the adoption of its products. Monthly fluctuations on the chart will reflect the growth in the number of patients using its wearable defibrillators and insurance company reimbursement decisions.
Monthly dynamics of market capitalization of the market segment - Heart
Kestra Medical Technologies is a company focused on saving lives from sudden cardiac arrest with its wearable cardioverter defibrillator. The dynamics of its sector, shown in the graph, reflect innovation in medicine. Against this backdrop, one can see how Kestra's unique product, designed to protect high-risk patients, is carving out a niche in the market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Healthcare stocks, especially in a critical area like cardiology, may be more resilient to market panics. The chart below shows the overall sentiment. Does Kestra Medical Technologies demonstrate defensive properties, or does its status as a tech startup make it vulnerable to general market risks?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Kestra Medical Technologies
Kestra Medical Technologies, a company developing wearable medical devices, particularly for the treatment of heart disease, whose weekly stock price reflects innovations in cardiology. News about clinical trials and regulatory approvals are driving highly volatile short-term trends.
Weekly dynamics of market capitalization of the market segment - Heart
Kestra, like other companies in the medical technology sector, reflects general trends. The chart compares its volatility with the industry to see how much of its growth is driven by the general trend toward innovation in cardiology and how much by unique product news.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Kestra Medical Technologies develops medical devices for the treatment of heart disease. The company's growth is driven by medical needs and innovation. The chart shows how KMTS stock is unaffected by overall market fluctuations, riding the wave of news about its technologies.
Market capitalization of the company, segment and market as a whole
KMTS - Market capitalization of the company Kestra Medical Technologies
Kestra Medical Technologies' stock price is a financial bet on saving lives during sudden cardiac arrest. The company's market cap reflects investors' faith in its wearable defibrillator. Its performance is a barometer of its ability to compete in the market and convince doctors and patients of the effectiveness of its solution for protecting against life-threatening arrhythmias.
KMTS - Share of the company's market capitalization Kestra Medical Technologies within the market segment - Heart
Kestra Medical Technologies develops innovative wearable defibrillators for patients at risk of sudden cardiac arrest. Its market capitalization in the medical devices sector reflects the life-saving potential of its technology. The chart below shows how the market views its competitive position in the cardiac device market.
Market capitalization of the market segment - Heart
Kestra Medical Technologies develops wearable defibrillators for patients at risk of sudden cardiac arrest. The chart below shows the overall market capitalization of the entire medical equipment sector. Its growth reflects the demand for innovative life-saving solutions.
Market capitalization of all companies included in a broad market index - GURU.Markets
Kestra Medical Technologies develops wearable defibrillators for patients at risk of sudden cardiac arrest. Its market capitalization chart tells the story of saving lives through technology, showing how this innovative medical device is fighting for its share of the cardiac equipment market.
Book value capitalization of the company, segment and market as a whole
KMTS - Book value capitalization of the company Kestra Medical Technologies
Kestra Medical develops wearable defibrillators. Its book value is derived from R&D equipment and capital. The chart below shows the material and financial basis for creating a vital medical device. Growth in this area is derived from investments in research and preparation for commercialization.
KMTS - Share of the company's book capitalization Kestra Medical Technologies within the market segment - Heart
Kestra Medical Technologies develops wearable defibrillators. Its business is the creation of complex medical hardware. The share price chart shows how the company invests in R&D centers and production lines to create the physical foundation for saving lives.
Market segment balance sheet capitalization - Heart
Kestra Medical Technologies develops wearable defibrillators for patients at risk of sudden cardiac arrest. This is a knowledge-intensive business, requiring investment in both R&D and the production of complex medical devices. The chart below shows how its intangible and tangible assets balance out on the path to commercialization.
Book value of all companies included in the broad market index - GURU.Markets
Kestra Medical's assets represent the capital and production base needed to save lives. The company's book value reflects its wearable defibrillator production capacity and R&D infrastructure. This is the material foundation upon which the development of innovative devices for patients at risk of sudden cardiac arrest is built.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Kestra Medical Technologies
Kestra Medical Technologies develops wearable defibrillators for patients at risk of sudden cardiac arrest. The company's book value is modest. Its market capitalization is a measure of its innovative technology, patents, and potential to save thousands of lives, creating a significant premium to its tangible assets.
Market to book capitalization ratio in a market segment - Heart
Kestra Medical Technologies develops wearable defibrillators for patients at risk of sudden cardiac arrest. The company's value lies in its proprietary technology and data. The chart shows how much its market capitalization, based on its lifesaving potential, exceeds its book value.
Market to book capitalization ratio for the market as a whole
Kestra Medical Technologies develops solutions for the treatment of sudden cardiac arrest. The company's value lies in its innovative medical devices and technologies. The market evaluates its ability to save lives and capture market share. The chart shows the premium investors place on breakthrough medical technologies compared to the market average.
Debts of the company, segment and market as a whole
KMTS - Company debts Kestra Medical Technologies
Kestra Medical Technologies, a company developing wearable defibrillators, is using debt financing to bring its product to market. This chart shows the capital raised for clinical trials, regulatory approvals, and the creation of commercial infrastructure. This represents an investment in technology that has the potential to save lives.
Market segment debts - Heart
Kestra Medical Technologies develops wearable defibrillators for patients at risk of sudden cardiac arrest. In the medical device sector, debt is essential to fund clinical trials, obtain approvals, and bring the product to market. The chart shows how the company's debt strategy relates to the capital-intensive process of commercializing medical devices.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Kestra Medical Technologies
Kestra Medical Technologies develops solutions for the treatment of sudden cardiac arrest. Medical technologies require significant investment in research, development, and regulatory approvals. This chart shows how the company is funding its path to market. Reliance on debt in the early stages can be extremely risky for investors.
Market segment debt to market segment book capitalization - Heart
Kestra Medical Technologies develops wearable defibrillators for patients at risk of sudden cardiac arrest. The cardiac device market requires robust clinical evidence and investment. The chart shows the overall debt burden in the medical device sector, helping to understand how Kestra is funding its innovation and entry into this important market.
Debt to book value of all companies in the market
Kestra Medical, a developer of wearable defibrillators, operates at the intersection of technology and medicine. This chart shows the overall market leverage. It helps assess how easy or difficult it is for such innovative companies to raise capital for long-term clinical trials and market entry, depending on overall economic conditions.
P/E of the company, segment and market as a whole
P/E - Kestra Medical Technologies
Kestra Medical Technologies develops solutions for the treatment of sudden cardiac arrest. This chart reflects investor expectations for its wearable defibrillator. Its value reflects the market's confidence in the company's ability to compete with existing solutions and capture a significant share of the life-saving medical device market.
P/E of the market segment - Heart
Kestra Medical Technologies is in the medical device sector. This chart shows the average price-to-earnings ratio for this innovative industry. Comparing the company's price-to-earnings ratio to this benchmark helps understand how highly the market values the commercial potential of its wearable defibrillator compared to other manufacturers of life-saving medical equipment.
P/E of the market as a whole
Kestra Medical Technologies develops wearable defibrillators for patients at risk of sudden cardiac arrest. The company's success depends on the implementation of its technology in clinical practice. This chart reflects sentiment in the medical technology sector. It helps understand whether the market sees Kestra's potential to save lives and capture significant market share, and how this compares to overall trends.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Kestra Medical Technologies
Kestra Medical Technologies is developing wearable cardioverter defibrillators for patients at risk of sudden cardiac arrest. This chart reflects investor expectations for the commercialization of its innovative medical device. The estimate is based on projected adoption of this technology in cardiology practice.
%20P%2FE%20Kestra%20Medical%20Technologies&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Kestra-Medical-Technologies&v=1772513682305 "Chart of the company's future (projected) P/E Kestra Medical Technologies")
Future (projected) P/E of the market segment - Heart
Kestra Medical Technologies develops solutions for the treatment of sudden cardiac arrest, including wearable defibrillators. This chart compares the company's future profitability expectations with the medical device sector. It reflects investor confidence in its technology and its ability to capture a significant share of the cardiac device market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Heart&v=1772513682334 "Future (projected) P/E graph of the market segment - Heart")
Future (projected) P/E of the market as a whole
Kestra Medical Technologies is developing wearable defibrillators for patients at risk of sudden cardiac arrest. The adoption of new medical devices depends on the willingness of healthcare systems and insurance companies to fund innovation. The overall economic climate, as illustrated by this graph, influences healthcare budgets and the speed of adoption of new, more effective technologies.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513682381 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Kestra Medical Technologies
Kestra Medical Technologies develops and manufactures wearable defibrillators for patients at risk of sudden cardiac arrest. The company's financial results depend on the successful commercialization of its products and reimbursement from insurance companies. This chart illustrates the trajectory of a medical technology company, where initial investments in R&D are followed by revenue growth.
Profit of companies in the market segment - Heart
Kestra Medical Technologies develops wearable defibrillators for patients at risk of sudden cardiac arrest. This chart, showing overall profitability in the medical device sector, reflects the demand for innovative lifesaving solutions. The success of Kestra's product and its acceptance by the medical community directly impacts treatment standards and the financial performance of the entire industry.
Overall market profit
Kestra Medical Technologies develops wearable defibrillators for patients at risk of sudden cardiac arrest. The company operates at the intersection of medicine and technology, offering a solution that can save lives. Its success depends on the implementation of this innovation in clinical practice, rather than on general economic conditions, which is typical for disruptive medical startups.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Kestra Medical Technologies
Kestra Medical Technologies develops and manufactures wearable defibrillators for patients at risk of sudden cardiac arrest. The future revenue projections you see depend on the successful commercialization of their product. Analysts are assessing the rate of adoption of the technology by doctors and patients, as well as the competitive landscape in the cardiac device market.
%20profit%20of%20the%20company%20Kestra%20Medical%20Technologies&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Kestra-Medical-Technologies&v=1772513682598 "Graph of future (projected) profit of the company Kestra Medical Technologies")
Future (predicted) profit of companies in the market segment - Heart
Kestra Medical Technologies develops and manufactures wearable defibrillators for patients at risk of sudden cardiac arrest. This chart shows overall profitability forecasts for the cardiac equipment sector. It helps understand how the company's innovative lifesaving solution fits into overall financial expectations for the medical technology market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Heart&v=1772513682625 "Graph of future (predicted) profits of companies in a market segment - Heart")
Future (predicted) profit of the market as a whole
Kestra Medical Technologies is developing wearable defibrillators for patients at risk of sudden cardiac arrest. Demand for these life-saving medical devices is driven by clinical need, not economic cycles. However, overall economic conditions, as reflected in this graph, can impact hospital budgets and the pace of adoption of new technologies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513682642 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Kestra Medical Technologies
Kestra Medical Technologies specializes in developing wearable cardioverter defibrillators for patients at risk of sudden cardiac arrest. For a medical technology company, this chart is crucial. It shows the premium investors are willing to pay for each dollar of revenue, believing in the potential of their innovative product to save lives and capture the market.
P/S market segment - Heart
Kestra Medical Technologies develops innovative solutions for the treatment of sudden cardiac arrest. The company aims to provide high-risk patients with wearable, easy-to-use lifesaving devices. This chart reflects the market's willingness to pay for revenue in the medical technology sector, demonstrating investor expectations for the commercialization of Kestra's products.
P/S of the market as a whole
Kestra Medical Technologies develops and commercializes wearable defibrillators and cardiac monitoring solutions, providing patients with protection against sudden cardiac arrest. This chart helps understand how investors value the revenue of companies creating innovative life-saving medical devices compared to the overall market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Kestra Medical Technologies
Kestra Medical Technologies develops wearable defibrillators for patients at risk of sudden cardiac arrest. This chart shows investors' estimates of the medical technology company's future revenue. It reflects the market's confidence in the commercial success of its innovative product and its ability to capture market share in lifesaving devices.
%20P%2FS%20Kestra%20Medical%20Technologies&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Kestra-Medical-Technologies&v=1772513682742 "The graph of the company's future (projected) P/S Kestra Medical Technologies")
Future (projected) P/S of the market segment - Heart
Kestra Medical Technologies develops and commercializes wearable defibrillators and solutions for monitoring patients at risk of sudden cardiac arrest. This chart compares investor expectations for its future revenue with the medical devices sector. The high valuation reflects expectations that its innovative devices will capture significant market share and save countless lives.
%20P%2FS%20market%20segment%20graph%20-%20Heart&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Heart&v=1772513682766 "Future (projected) P/S market segment graph - Heart")
Future (projected) P/S of the market as a whole
Kestra Medical Technologies develops wearable defibrillators for patients at risk of sudden cardiac arrest. The company's success depends on the adoption of its technology in medical practice. This graph of investor expectations reflects their belief that innovative medical devices can not only save lives but also generate significant revenue.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513682775 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Kestra Medical Technologies
This graph illustrates the potential revenue of a company developing cutting-edge cardiac technologies. Revenue will be generated from the sale or leasing of its devices for monitoring or treating cardiac conditions. Growth in this figure will reflect the successful implementation of its products in clinical practice and the saving of patient lives.
Sales of companies in the market segment - Heart
Kestra Medical Technologies has developed a wearable cardioverter defibrillator (WCD) for patients at risk of sudden cardiac arrest. The company's device offers a cutting-edge life-saving solution. This chart represents the total revenue of the entire cardiac medical device market, demonstrating the demand for the innovative products Kestra creates.
Overall market sales
Kestra Medical Technologies develops wearable defibrillators for patients at risk of sudden cardiac arrest. Demand for its medical device is driven by healthcare system needs and physician decisions. The overall economic situation, illustrated in this graph, impacts hospital budgets and insurance coverage, which are key factors in the adoption of new medical technologies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Kestra Medical Technologies
Kestra Medical Technologies develops and manufactures wearable defibrillators for patients at risk of sudden cardiac arrest. The company's success depends on the adoption of its technology in medical practice and securing insurance coverage. This chart reflects analysts' forecasts for cardiac device market growth and the adoption of innovative solutions.
%20sales%20of%20the%20company%20Kestra%20Medical%20Technologies&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Kestra-Medical-Technologies&v=1772513682876 "Schedule of future (projected) sales of the company Kestra Medical Technologies")
Future (projected) sales of companies in the market segment - Heart
Kestra Medical Technologies develops innovative solutions for the treatment of sudden cardiac arrest. This chart displays projected sales of their wearable cardioverter defibrillators. The data shows analysts' assessment of the market potential of this medical device and its ability to compete with existing treatments.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Heart&v=1772513682886 "Schedule of future (projected) sales of companies in the market segment - Heart")
Future (projected) sales of the market as a whole
This graph, reflecting the state of the healthcare system, is important for Kestra Medical Technologies. The company develops wearable defibrillators for patients at risk of sudden cardiac arrest. Demand for its products depends on hospital budgets and the willingness of insurance companies to cover the costs of innovative medical devices.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513682903 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Kestra Medical Technologies
Kestra Medical Technologies develops and manufactures wearable defibrillators for patients at risk of sudden cardiac arrest. This chart reflects the company's financial performance during the commercialization phase. Profitability depends on successful market penetration, insurance reimbursement, and scaling up production of this vital device.
Market segment marginality - Heart
Kestra Medical Technologies specializes in developing wearable cardioverter defibrillators for patients at risk of sudden cardiac arrest. The company's profitability depends on the implementation of its innovative medical devices. This chart shows the average profitability in the sector, helping to assess the relevance of Kestra's technology in cardiology.
Market marginality as a whole
Kestra Medical Technologies develops wearable defibrillators for patients at risk of sudden cardiac arrest. Demand for such advanced medical equipment depends on healthcare systems and insurance coverage. This dynamic, reflecting the overall economic situation, impacts hospital and insurance company budgets, determining their ability to purchase expensive, innovative devices.
Employees in the company, segment and market as a whole
Number of employees in the company Kestra Medical Technologies
Kestra Medical Technologies develops and manufactures a wearable cardioverter defibrillator for patients at risk of sudden cardiac arrest. This graph reflects the size of its team of engineers, clinicians, and sales specialists. The growth in the graph reflects the expansion of commercial activities and efforts to introduce their life-saving device into clinical practice.
Share of the company's employees Kestra Medical Technologies within the market segment - Heart
Kestra Medical Technologies develops innovative wearable defibrillators for patients at risk of sudden cardiac arrest. Creating such a complex medical device requires an elite team of engineers and clinicians. This chart shows Kestra's share of the total number of specialists in this niche, reflecting its technological potential and focus on saving lives.
Number of employees in the market segment - Heart
Kestra Medical Technologies develops and manufactures wearable defibrillators for patients at risk of sudden cardiac arrest. This chart reflects employment in the cardiac medical equipment sector. The growing number of specialists in this field reflects technological advances and increased awareness of cardiovascular disease, expanding the market for Kestra's innovative devices.
Number of employees in the market as a whole
Kestra Medical Technologies develops solutions for the treatment of sudden cardiac arrest. Their growth depends on the clinical adoption of their wearable defibrillator. This overall employment rate is irrelevant to their niche business. The key drivers of hiring are regulatory approval and recognition of their technology by the medical community.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Kestra Medical Technologies (KMTS)
Kestra Medical Technologies develops wearable defibrillators. As a medical device company, it combines cutting-edge research with the need for precision manufacturing and clinical support. This metric reflects the balance between the high value of its intellectual property and the staff required for production and market launch.
%20of%20the%20company%20Kestra%20Medical%20Technologies%20(KMTS)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Kestra-Medical-Technologies-KMTS&v=1772513683275 "Chart of market capitalization per employee (in thousands of dollars) of the company Kestra Medical Technologies (KMTS)")
Market capitalization per employee (in thousands of dollars) in the market segment - Heart
Kestra Medical Technologies (KMTS) develops medical devices, specifically a wearable defibrillator (WCD) for patients at risk of sudden cardiac arrest. This is a high-tech medical product. Its value lies in its technology and patents. This chart shows how the market values such medical innovations.
%20by%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Heart&v=1772513683312 "Market capitalization per employee (in thousands of dollars) by market segment - Heart")
Market capitalization per employee (in thousands of dollars) for the overall market
Kestra Medical Technologies develops solutions for the treatment of sudden cardiac arrest. In the medical device industry, market capitalization is determined by the uniqueness of a technology and its life-saving potential. This metric reflects the high value the market places on the intellectual capital generated by a team of engineers and clinicians to solve a critical medical problem.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513683339 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Kestra Medical Technologies (KMTS)
Kestra Medical Technologies (KMTS) develops and manufactures a wearable cardioverter defibrillator (W-AED) for patients at risk of sudden cardiac arrest. This medical device requires significant investment in R&D and clinical data. This graph shows the costs (likely negative profit) per employee to bring this complex device to market.
%20Chart%20Kestra%20Medical%20Technologies%20(KMTS)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Kestra-Medical-Technologies-KMTS&v=1772513683374 "Company Profit Per Employee (in thousands of dollars) Chart Kestra Medical Technologies (KMTS)")
Profit per employee (in thousands of dollars) in the market segment - Heart
Kestra Medical is an R&D startup developing a wearable defibrillator (the "ASSURE" system) to "protect" against sudden cardiac arrest. This chart shows the benchmark for the "R&D Sector." In this sector, the benchmark is *deeply negative*. This is a "pure" R&D race. Profit per employee (engineer) is the goal of the future; currently, it's a "burnout" of the R&D budget.
%20in%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Heart&v=1772513683408 "Chart of profit per employee (in thousands of dollars) in the market segment - Heart")
Profit per employee (in thousands of dollars) for the market as a whole
Kestra Medical Technologies (KMTS) is a company focused on sudden cardiac arrest. They have developed a wearable defibrillator (ASSURE), which patients wear under their clothing. It is a cutting-edge medical device. This chart helps understand how the wearable medicine business, which requires R&D and complex manufacturing, compares in terms of personnel efficiency compared to the market.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513683432 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Kestra Medical Technologies (KMTS)
Kestra Medical Technologies develops solutions for the treatment of sudden cardiac arrest. As a medical startup in the early commercialization stage, the company has modest revenue per employee. This chart tracks the market adoption of its innovative product and the initial sales growth phase, which is critical to its future.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Kestra-Medical-Technologies-KMTS&v=1772513683447 "Sales chart per company employee Kestra Medical Technologies (KMTS)")
Sales per employee in the market segment - Heart
Kestra Medical Technologies has developed a wearable defibrillator (WCD)—a vest worn by patients at high risk of sudden cardiac arrest. It's a medical device-as-a-service. This graph shows how productive their team (engineers, physicians, and support staff) is. It reflects their ability to monetize this vital technology.
Sales per employee for the market as a whole
Kestra Medical Technologies (KMTS) is a medical technology company that has developed a wearable cardioverter defibrillator (WCD) for patients at risk of sudden cardiac arrest. It is an innovative medical device. During the commercialization phase, this chart shows how successfully the company is growing sales. Revenue is generated by the sales and support team, and effectiveness depends on the product's acceptance by physicians.
Short shares by company, segment and market as a whole
Shares shorted by company Kestra Medical Technologies (KMTS)
Kestra Medical Technologies is developing a wearable defibrillator (WCD) for patients at high risk of sudden cardiac arrest. This device monitors and, if necessary, delivers a shock. This graph shows the level of skepticism. "Bearers" may doubt the company's ability to compete with the market leader (Zoll) or that its technology will gain widespread acceptance among doctors and insurance companies.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Kestra-Medical-Technologies-KMTS&v=1772513683508 "Short Shares Chart for the Company Kestra Medical Technologies (KMTS)")
Shares shorted by market segment - Heart
Kestra Medical (KMTS) develops wearable medical devices, specifically a wearable defibrillator (WCD) for patients at risk of sudden cardiac arrest. This chart shows bets against the cardiac equipment sector. Shorting this sector may indicate that investors doubt the company's ability to compete with giants like Zoll or see problems with insurance reimbursement.
Shares shorted by the overall market
Kestra (KMTS) is a medical technology company (cardiology). This indicator (`Short_All`) is a mirror of market fear. When it rises, investors panic and shed risk. Biotech stocks, even those with approved drugs, often suffer sell-offs when general pessimism rules the market.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Kestra Medical Technologies (KMTS)
Kestra Medical Technologies is developing wearable defibrillators. This is a speculative R&D story in medical technology. A chart above 70 may reflect positive news about trials or approvals. Oversold levels (<30) are often associated with delays, setbacks, or general investor risk aversion.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Kestra-Medical-Technologies-KMTS&v=1772513683558 "RSI 14 indicator chart for the company's stock Kestra Medical Technologies (KMTS)")
RSI 14 Market Segment - Heart
Kestra Medical Technologies develops innovative wearable medical devices. Its flagship product is a wearable defibrillator (WCD) for patients at risk of sudden cardiac arrest. This graph tracks the collective momentum in the cardiovascular medical technology sector. It helps us understand whether KMTS's momentum is unique or reflects a general overheating of the medtech sector.
RSI 14 for the overall market
Kestra Medical (KMTS) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast KMTS (Kestra Medical Technologies)
Kestra Medical Technologies (KMTS) is a company focused on saving lives from sudden cardiac arrest. It has developed the ASSURE wearable cardioverter defibrillator (WCD). This chart shows the average 12-month Wall Street forecast. It reflects analysts' assessments of the speed of adoption of this technology by doctors and patients, as well as insurance reimbursement prospects.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-KMTS-Kestra-Medical-Technologies&v=1772513683643 "A chart showing analyst consensus forecasts for the expected stock price. KMTS (Kestra Medical Technologies)")
The difference between the consensus estimate and the actual stock price KMTS (Kestra Medical Technologies)
Kestra Medical is a company (likely privately held or early-stage) focused on cardiac medicine, specifically the development of wearable defibrillators. This chart (hypothetically) would reflect analysts' faith in its R&D platform and its ability to compete in the sudden cardiac arrest market, seeing potential therein.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-KMTS-Kestra-Medical-Technologies&v=1772513683702 "A chart showing the difference between the consensus forecast and the actual stock price. KMTS (Kestra Medical Technologies)")
Analyst consensus forecast for stock prices by market segment - Heart
Kestra Medical is a privately held company (perhaps a typo in the ticker symbol, or it recently went public) specializing in wearable defibrillators for patients at risk of sudden cardiac arrest. This chart shows general expectations for the cardiac device sector. It reflects whether experts believe the wearable medical device market will grow.
Analysts' consensus forecast for the overall market share price
Kestra Medical is an innovative company that developed a wearable defibrillator (ASSURE). This chart of overall market sentiment is important. Optimism = hospitals and insurers are more willing to invest in and cover new technologies. During a recession (pessimism), they may prefer older, proven, and less expensive treatment methods.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Kestra Medical Technologies
Kestra Medical is a lifesaving company. They develop wearable cardiac devices (like defibrillators) for patients at high risk of sudden cardiac arrest. This chart is an assessment of their medical technology. It reflects their progress in obtaining FDA approvals, their ability to compete with market leaders, and the potential for hospital adoption of their devices.
AKIMA Market Segment Index - Heart
Kestra Medical is a heart saver; the company has developed an innovative wearable defibrillator (ASSURE) for patients at high risk of sudden cardiac arrest. This composite metric evaluates medical technology companies. The graph shows the average value for the segment. This benchmark: how does this breakthrough technology (KMTS) differentiate it from the average competitor?
The AKIM Index for the overall market
Kestra Medical is a medtech company specializing in wearable medical technology, specifically defibrillators for women. This chart, which reflects the market average, provides context. It helps assess how this growth story in a niche healthcare segment, dependent on physician adoption, compares to overall macroeconomic trends.
